STOXPO
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
STOXPO
No Result
View All Result
Home Companies Mid-Cap

Chewy’s Q2 FY24 Results: A Turnaround in Active Customer Growth and Optimistic FY24 Outlook

byLuca Blaumann
August 29, 2024
in Mid-Cap, Retail
Reading Time: 5 mins read
Share on TwitterShare on LinkedIn

Chewy Beats Earnings Expectations, Raises Guidance Amid Strong Margins and Stabilizing Market Conditions

Chewy (CHWY), the leading online retailer of pet products, delivered a strong performance in its second quarter of fiscal year 2024, beating expectations on the bottom line and raising its full-year guidance. The company’s ability to grow its active customer base for the first time in over a year, coupled with robust margins and a conservative yet optimistic outlook, marks a potential turning point for the e-commerce giant in a challenging market environment.

Solid Q2 Performance: A Mix of Growth and Stability

In Q2 FY24, Chewy reported revenue of $2.86 billion, marking a 2.6% year-over-year increase. This figure aligned with the high end of the company’s guided range of $2.84-$2.86 billion and met consensus expectations. However, the standout performance came from Chewy’s bottom line, where it sharply beat expectations with an adjusted EBITDA of $145 million, or 5.1% of sales, far surpassing the consensus estimate of $111 million (3.9%).

One of the most significant developments in this quarter was the growth in Chewy’s active customer base. The company reported 20 million active customers, slightly above the consensus forecast of 19.97 million and better than Chewy’s internal estimate of 19.93 million. This marks the first time in over a year that Chewy has grown its active customer count, a key performance indicator (KPI) that had previously been under pressure. The increase was driven by stronger-than-expected new customer acquisitions and an accelerated pace of customer reactivation, fueled by Chewy’s enhanced Customer Relationship Management (CRM) strategies and targeted marketing initiatives.

Net sales per active customer (NSPAC) came in at $565, slightly below the consensus of $567 but still representing a record high for the company. Despite the ongoing disinflation in pet food prices, Chewy managed to increase spending per customer, thanks to its successful wallet share initiatives, which encouraged customers to spend more across a broader range of products.

Chewy’s gross margins also outperformed expectations, reaching 29.5%, up 120 basis points year-over-year and above the consensus estimate of 28.9%. This margin strength was largely driven by the company’s high-margin sponsored ads program and a higher mix of healthcare product sales. Additionally, Chewy demonstrated impressive cost control, with Selling, General & Administrative (SG&A) expenses accounting for 18.8% of sales, better than the consensus estimate of 19.2%. This efficiency was supported by disciplined corporate payroll management and gains from the company’s automated distribution centers.

Raised FY24 Guidance: Conservative Yet Encouraging

Following its strong Q2 results, Chewy raised its full-year FY24 guidance, reflecting continued confidence in its business model. The company now expects full-year revenue in the range of $11.6-$11.8 billion, maintaining its previous outlook but implying slightly lower sales growth in the second half of FY24 compared to consensus expectations. However, the company also raised its adjusted EBITDA margin guidance to 4.5-4.7%, up from the prior range of 4.1-4.3%, indicating stronger profitability in the face of softer sales growth.

For Q3 FY24, Chewy guided revenue between $2.84 billion and $2.86 billion, representing a year-over-year growth of 3.4% to 4.2%. While this guidance is slightly below the consensus midpoint of $2.86 billion, it reflects Chewy’s conservative approach, particularly in light of the ongoing economic uncertainty and fluctuating consumer demand.

Chewy’s ability to maintain flat year-over-year active customer numbers by the end of FY24, despite exceeding expectations in the first half, further underscores the company’s cautious outlook. The company is aware of the challenges posed by the elevated retention headwinds from its first half of FY23 cohorts, which had a higher mix of discount-driven customers, potentially pressuring churn rates.

Market Trends and Competitive Landscape

Chewy’s Q2 performance and guidance offer positive read-throughs for the broader pet industry. The company continues to gain market share and expand its margins despite operating in a soft industry environment. Chewy reported encouraging trends in pet household formation, with net adoptions up in the low teens year-over-year and relinquishments down in the low to mid-single digits. These trends, coupled with the stabilization of discretionary demand and promotional activity, are encouraging signs for the pet retail market.

The company’s growth in sponsored ads and high-margin pharmacy product sales are expected to continue driving margin expansion into the second half of FY24. Sponsored ads contributed materially to Q2 and Q1 margin strength, and the program is on track to reach approximately 1% of sales in FY24. Additionally, Chewy’s improved fulfillment network, which contributed about 20 basis points to SG&A leverage in Q2, is poised to deliver further benefits as volumes potentially accelerate in the second half.

Outlook for FY24 and Beyond

Looking ahead, Chewy’s FY24 outlook appears conservative but achievable, with potential upside if industry demand remains stable or improves. The company’s strategic initiatives, including the growth of its sponsored ads program, cross-sales of high-margin products, and disciplined cost management, position it well for continued margin expansion.

Beyond FY24, Chewy is expected to return to mid-single-digit to high-single-digit revenue growth, with sustained margin improvement driven by the favorable mix of high-margin products and services. However, SG&A leverage may be limited as the company reinvests in growth initiatives.

One potential near-term challenge for Chewy’s stock is the possibility of additional stock sales by private equity owner BC Partners, which could cap share price appreciation. However, the company’s long-term fundamentals remain strong, and analysts continue to rate Chewy as an “Outperform” with a target price of $35.

Chewy’s Q2 FY24 results mark a positive turning point for the company, with growth in active customers, strong margins, and an optimistic outlook for the remainder of the year. While the guidance remains conservative, the company’s strategic initiatives and disciplined execution provide a solid foundation for future growth. As Chewy navigates the competitive landscape and evolving market conditions, its ability to capitalize on high-margin opportunities and maintain customer engagement will be key to sustaining its upward trajectory.

You might like this article:Affirm’s Solid Q4 Performance and Optimistic FY25 Guidance: A Mixed Outlook Amidst Fierce Competition

Tags: BreakingEarningsGrowthMoversNewsStock Market
Previous Post

Affirm’s Solid Q4 Performance and Optimistic FY25 Guidance: A Mixed Outlook Amidst Fierce Competition

Next Post

Eos Energy Enterprises Secures $30 Million Milestone, Paving the Way for Growth in Long-Duration Energy Storage

Related Posts

drugs-3

Hims & Hers Health Doubles Revenue in Q1 2025, Raises Full-Year Outlook

byLuca Blaumann
May 5, 2025
0

Surging subscriber growth and profitability prompt ambitious long-term targets for 2030 Hims & Hers Health, Inc. (HIMS), a leading digital...

amazon

Amazon Delivers Strong Q1 Results but Cautions on Tariffs and Trade Pressures

byLuca Blaumann
May 1, 2025
0

Cloud and ad revenue drive quarterly beat, but light guidance and tariff concerns drag stock lower Amazon (AMZN) reported better-than-expected...

GameStop

GameStop CEO Ryan Cohen Must Face Lawsuit Over $47 Million Bed Bath & Beyond Stock Windfall

byLiliana Vida
April 21, 2025
0

Judge rules Cohen must defend insider trading claims over 2022 stake in bankrupt retailer Ryan Cohen, the billionaire CEO of...

Next Post
warner bros discovery

Eos Energy Enterprises Secures $30 Million Milestone, Paving the Way for Growth in Long-Duration Energy Storage

Latest News

Mira Pharmaceuticals Approves Acquisition of SKNY, Creating $60M+ Biotech Platform

Trump Crypto Advisor David Bailey Raises $300M for New Public Bitcoin Investment Firm

Uber Forecasts Strong Q2 Despite Mixed Q1 Results and Economic Headwinds

AMD Kicks Off 2025 With Strong Q1 Growth Driven by AI and Data Center Demand

Constellation Energy Shares Surge on Revenue Beat and AI-Driven Demand

Based on Your Interest

IT Services

Palantir Soars in Q1 2025 with 39% Revenue Growth, Raises Full-Year Outlook Amid Soaring U.S. Commercial Demand

May 5, 2025
drugs-3
Biotechnology

Hims & Hers Health Doubles Revenue in Q1 2025, Raises Full-Year Outlook

May 5, 2025
amazon
Internet

Amazon Delivers Strong Q1 Results but Cautions on Tariffs and Trade Pressures

May 1, 2025

Recommended

Entertainment

Meta Delivers Strong Q1 Results as AI Push Accelerates, but EU Regulation Looms

April 30, 2025
Artificial Intelligence

Qualcomm Tops Q2 Expectations but Cautions on Trade Risks and Smartphone Demand

April 30, 2025
Artificial Intelligence

Nvidia CEO Urges U.S. to Loosen AI Export Rules Amid Rising Global Competition

April 30, 2025
Biotechnology

Novo Nordisk Expands Wegovy Access Through Telehealth Providers

April 29, 2025
Aerospace & Defense

Boeing Shares Climb After Analyst Upgrade and Spirit AeroSystems Breakthrough

April 28, 2025
Stoxpo

Follow us on social media:

Highlights

  • Mira Pharmaceuticals Approves Acquisition of SKNY, Creating $60M+ Biotech Platform
  • Trump Crypto Advisor David Bailey Raises $300M for New Public Bitcoin Investment Firm
  • Uber Forecasts Strong Q2 Despite Mixed Q1 Results and Economic Headwinds
  • AMD Kicks Off 2025 With Strong Q1 Growth Driven by AI and Data Center Demand
  • Constellation Energy Shares Surge on Revenue Beat and AI-Driven Demand

Category

  • Blog
  • Communication Services
    • Entertainment
    • Internet
    • Telecommunications
  • Companies
    • Large-Cap
    • Mega-Cap
    • Micro-Cap
    • Mid-Cap
    • Small-Cap
  • Consumer Cyclical
    • Auto Manufacturers
    • Casinos & Gambling
    • Ground Transportation
    • Hospitality
      • Casinp
      • Resorts & Lodging
      • Restaurants
      • Travel
        • Airlines
    • Retail
    • Textiles, Apparel & Luxury Goods
  • Consumer Defensive
    • Beverages
    • Discount Stores
    • Distributor
    • Ecommerece
    • Electrical Equipment
    • Foods
    • Household & Personal Products
    • Leisure Products
    • Tobacco
  • Contributions
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Economy
  • Energy
    • Electric
    • Oil & Gas
    • Renewables
  • Financial Services
    • Asset Management
    • Banks
    • Brokerages
    • Credit Services
    • Insurance
  • Healthcare
    • Biotechnology
    • Medical Devices
    • Pharmaceuticals
  • Industrials
    • Aerospace & Defense
    • Construction
    • Industrial Machinery
  • Materials
    • Building Materials
    • Chemicals
    • Gold
    • Mining
    • Silver
    • Steel
  • Q&A's
  • Real Estate
  • Technology
    • Artificial Intelligence
    • Computer Hardware
    • Consumer Electronics
    • Cybersecurity
    • IT Services
    • Semiconductors
    • Software
  • Utilities

Latest News

chemistry

Mira Pharmaceuticals Approves Acquisition of SKNY, Creating $60M+ Biotech Platform

May 8, 2025

Trump Crypto Advisor David Bailey Raises $300M for New Public Bitcoin Investment Firm

May 8, 2025

Uber Forecasts Strong Q2 Despite Mixed Q1 Results and Economic Headwinds

May 7, 2025
  • About
  • Privacy Policy
  • Contact

© 2024 All Rights Reserved: STOXPO.

No Result
View All Result
  • Latest News
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Technology
    • Software
    • Semiconductors
  • Crypto
    • Bitcoin
    • Ethereum
    • Altcoins
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions

© 2024 All Rights Reserved: STOXPO.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information

Accept Cookie Settings
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookie Settings

Do you really wish to opt-out?